Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health CarelonRx by Year
CarelonRx — Unaffiliated (External Third-Party) Operating Revenue ($M)
Elevance Health CarelonRx: $24,483M in FY2025, up 8.2% from a year earlier.
Latest, FY2025
24,483
Period ended Dec 31, 2025
Change on a year earlier
+8.2%
22,635 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Operating revenue - unaffiliated | 167,094 | 24,483 | 7,141 | 31,624 | — | ( 1,134 ) | 197,584”
Source: 10-K (FY2025, 2026-02-06) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — Unaffiliated (External Third-Party) Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24,483 | +8.2% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | 22,635 | +16.3% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 19,458 | +29.9% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 14,978 | +18.3% | 10-K (FY2024, 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 12,657 | – | 10-K (FY2023, 2024-02-21) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx ($M), annual FY2021–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-carelonrx-rev-unaffiliated
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.